Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML
however, their effects on OA incidence remain incompletely understood
a medical professional creates a custom plan for you, starting with a low dose and adjusting it based on your progress to ensure a safe and comfortable experience
Since then, the idea of liver cirrhosis as a condition of IGF-I deficiency during adult age has been yearly consolidated from a number of publications establishing the origin of this lack from a decrease in GH receptors seen in cirrhotic livers[216] and a progressive reduction of liver synthesis capability from decreased hepatocellular mass in advanced stages[209]
Definitely not ( except, of course, when we talk about its known risk of causing birth defects , which is why regular blood tests, pregnancy tests, and birth control is required while taking the drug)